Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.32 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.32 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2925049 | 0.91 | TSHR (0.56) | TSHRLMNAMAPTALDH1A1 | |
| SCHEMBL8155595 | 0.91 | EGLN1 (0.43) | TSHRLMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL376947 | 0.90 | ALDH1A1 (0.50) | TSHRLMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL11093080 | 0.90 | LMNA (0.47) | TSHRLMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL11159880 | 0.90 | LMNA (0.52) | TSHRLMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL10884007 | 0.88 | LMNA (0.55) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL28684939 | 0.86 | LMNA (0.53) | TSHRLMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL11838215 | 0.84 | TSHR (0.37) | TSHRLMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL10419385 | 0.84 | LMNA (0.62) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL10439670 | 0.84 | TSHR (0.46) | TSHRLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2812074-B1 | MODIFIED RELEASE FORMULATIONS OF VILOXAZINE | SUPERNUS PHARMACEUTICALS INC (US) | 2023-05-10 | — | — | EP | claimed |
| EP-3664778-B1 | PHARMACEUTICAL PREPARATION COMPRISING 3-FLUORO-4-[7-METHOXY-3-METHYL-8-(1-METHYL-1 H-PYRAZOL-4-YL)-2-OXO-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL]-BENZONITRILE | MERCK PATENT GMBH (DE) | 2022-05-25 | — | — | EP | claimed |
| CN-113980252-A | Continuous production method of modified poly (butylene succinate) | 上海师范大学 | 2022-01-28 | — | — | CN | claimed |
| EP-3725778-B1 | FORMULATIONS OF ENZALUTAMIDE | MEDIVATION PROSTATE THERAPEUTICS LLC (US) | 2021-08-18 | — | — | EP | claimed |
| EP-3662894-B1 | NANOPARTICLES COMPRISING TACROLIMUS | LEON NANODRUGS GMBH (DE) | 2021-07-28 | — | — | EP | claimed |
| WO-2021118403-A1 | SYSTEM FOR DELIVERING 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR PERORAL ADMINISTRATION | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" | 2021-06-17 | — | — | WO | claimed |
| EP-2476439-B2 | PRODUCTION METHOD FOR ENTERIC HARD CAPSULES | LOTTE FINE CHEMICAL CO LTD (KR) | 2019-09-25 | — | — | EP | claimed |
| EP-2997953-B1 | DELIVERY DEVICE FOR ORAL INTAKE OF AN AGENT | INTEC PHARMA LTD (IL) | 2018-12-26 | — | — | EP | claimed |
| EP-2893928-B1 | HYDROMORPHONE HYDROCHLORIDE-CONTAINING ORAL SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION | DAIICHI SANKYO CO LTD (JP) | 2018-10-24 | — | — | EP | claimed |
| EP-2659881-B1 | A delayed release drug formulation | TILLOTTS PHARMA AG (CH) | 2017-11-29 | — | — | EP | claimed |
| EP-2254552-B1 | LONG-TERM STABLE PHARMACEUTICAL PREPARATION HAVING THE ACTIVE INGREDIENT GLYCEROL TRINITRATE | POHL BOSKAMP G GMBH & CO KG (DE) | 2016-08-24 | — | — | EP | claimed |
| EP-1951868-B1 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA INC (US) | 2015-01-07 | — | — | EP | claimed |
| EP-2178519-B1 | Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer | BEND RES INC (US) | 2012-04-25 | — | — | EP | claimed |
| EP-1404302-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING ADSORBATES OF AMORPHOUS DRUG | PFIZER PROD INC (US) | 2010-11-03 | — | — | EP | claimed |
| EP-1399190-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING LOW-SOLUBILITY AND ACID-SENSITIVE DRUGS AND NEUTRALIZED ACIDIC POLYMERS | BEND RES INC (US) | 2010-09-08 | — | — | EP | claimed |
| EP-1499300-B1 | PHARMACEUTICAL FORMULATIONS WITH IMPROVED BIOAVAILABILITY | SUPERNUS PHARMACEUTICALS INC (US) | 2009-03-18 | — | — | EP | claimed |
| EP-1024401-B1 | Alkaline soluble mixture composed of cellulose derivatives | FERRANIA TECHNOLOGIES SPA (IT) | 2006-11-08 | — | — | EP | claimed |
| EP-3805327-B1 | ANTIFOULING PAINT COMPOSITION | MITSUBISHI CHEM CORP (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-1906926-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 2 , 3-DIHYDRO-6-NITROIMIDAZO Ý2 , 1-B¨OXAZOLE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007013477-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 2 , 3-DIHYDRO-6-NITROIMIDAZO [2 , 1-B] OXAZOLE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-02-01 | — | — | WO | disclosed |